NumFin

Ironwood Pharmaceuticals, Inc.

符号: IRWD

NASDAQ

6.74

USD

今天的市场价格

  • -1.0492

    市盈率

  • 0.1032

    PEG比率

  • 1.07B

    MRK市值

  • 0.00%

    DIV收益率

Ironwood Pharmaceuticals, Inc. (IRWD) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Ironwood Pharmaceuticals, Inc. (IRWD). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Ironwood Pharmaceuticals, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

092.2656.2620.1
362.6
177
173.2
221.4
305.2
439.4
248.3
197.6
168.2
164
248
123.1
89.8
91.9

balance-sheet.row.short-term-investments

0000
0
0
0
95.7
251.2
178.1
174
122.1
31.5
76.7
203.7
0
22
29.5

balance-sheet.row.net-receivables

0129.1115.5114
122.4
117.2
81
82.2
64.9
54.5
25.8
3.2
1.5
0.7
2.9
5.2
7.1
25.5

balance-sheet.row.inventory

001.31.3
0
0.6
0
0.7
1.1
0
5
22.1
6.7
0
-239.9
0
2.5
0

balance-sheet.row.other-current-assets

0127.79.8
9.2
11.9
12.3
7.3
9
6.3
10.6
6.2
8
2.9
248
3.1
8.7
1.7

balance-sheet.row.total-current-assets

0233.3780.6745.2
495.8
306.9
266.4
311.6
380.2
500.2
289.7
229.1
184.4
167.6
259.1
131.4
108.1
119.2

balance-sheet.row.property-plant-equipment-net

018.220.322.9
25.5
30.2
17.3
17.3
20.5
21.1
29.8
37.4
37.5
33.6
34.4
22.6
24.6
4.1

balance-sheet.row.goodwill

0000
0.8
0.8
0.8
0.8
0.8
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

03.700
0
0
0
159.9
166.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

03.7-15.1-24.5
0.8
0.8
0.8
160.7
166.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0015.124.5
37
64.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0212.3283.7333.3
-37
-64.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

03.615.925.5
37.1
64.9
47.6
116.1
142.2
97.8
14
12.5
7.9
7.8
7.9
8.5
8
12.6

balance-sheet.row.total-non-current-assets

0237.8319.9381.7
63.4
95.9
65.6
294.1
329.6
118.9
43.8
49.8
45.5
41.4
42.3
31
32.6
16.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0471.11100.51126.9
559.2
402.7
332.1
605.7
709.8
619.1
333.5
279
229.9
209
301.4
162.5
140.7
135.9

balance-sheet.row.account-payables

07.80.50.9
0.7
5.5
71.6
61.5
62.9
36.1
35.9
32
48.6
6.4
21.4
4.9
6.1
5.6

balance-sheet.row.short-term-debt

0202.73.1120
3.1
1.1
47.6
4.1
6.2
27.6
12.4
1.1
0.3
0.2
0.2
1.5
1.1
1

balance-sheet.row.tax-payables

01.20.70.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0498.3412.9355.8
450.6
430.1
366.3
396.1
366.6
353.9
164.9
177.8
0.3
0.4
0.4
1.9
1.1
2

Deferred Revenue Non Current

0000
0
0
0
0
0
1.8
9
11.4
18
21.1
77
104.1
48.2
58.6

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

064.3221.3
0.5
33.4
0.1
0.2
14.2
5.5
5
2.8
2.7
22.2
0
17.3
14
7.5

balance-sheet.row.total-non-current-liabilities

0541.3422.6359.3
463.9
455.1
408.9
529.8
552
447.5
184.4
199.7
30.9
34
77.4
404.4
332
284.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

014.519.721.6
23.4
23.2
0.2
4.1
6.3
2.9
3.7
4.3
0.6
0.7
0.6
0.3
0.3
0

balance-sheet.row.total-liab

0817.4448.1521
496.6
496
528.4
595.8
643.1
524
245
240.7
85.9
99.1
141.8
460.8
371.1
314.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
298.4
0
0

balance-sheet.row.common-stock

00.20.20.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0

balance-sheet.row.retained-earnings

0-1698.6-696.4-937.6
-1466.1
-1572.2
-1591.1
-1308.8
-1191.8
-1110.1
-967.4
-777.8
-505
-432.4
-367.5
-314.6
-243.4
-189.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-300
0
0
0
-0.1
0
-0.1
0
0
0
0
0
-298.4
0
0

balance-sheet.row.other-total-stockholders-equity

01355.21348.61543.4
1528.5
1478.8
1394.6
1318.5
1258.4
1205.2
1055.9
815.9
649
542.1
527
13
7.6
4.6

balance-sheet.row.total-stockholders-equity

0-346.3652.4605.9
62.6
-93.3
-196.4
9.8
66.7
95.1
88.6
38.2
144.1
109.9
159.6
-301.6
-235.8
-184.9

balance-sheet.row.total-liabilities-and-stockholders-equity

0471.11100.51126.9
559.2
402.7
332.1
605.7
709.8
619.1
333.5
279
229.9
209
301.4
162.5
140.7
135.9

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
3.2
5.3
6.5

balance-sheet.row.total-equity

0-346.3652.4605.9
62.6
-93.3
-196.4
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0015.124.5
37
64.9
0
95.7
251.2
178.1
174
122.1
31.5
76.7
203.7
0
22
29.5

balance-sheet.row.total-debt

0715.5415.9475.8
453.7
431.2
413.9
400.2
372.8
381.5
177.3
178.9
0.6
0.7
0.6
3.3
2.1
3

balance-sheet.row.net-debt

0623.4-240.3-144.3
91.1
254.2
240.8
274.4
318.8
120.2
103
103.5
-136.1
-86.6
-43.7
-119.8
-65.6
-59.5

现金流量表

在 Ironwood Pharmaceuticals, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

0-1002.2175.1528.4
106.2
21.5
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.9
-56.4
-73.3
-55
-53.2

cash-flows.row.depreciation-and-amortization

01.61.41.5
3.6
5.6
14.2
14.6
11.3
11.6
12.3
11.7
11.3
10
6.2
5.3
2.8
1.7

cash-flows.row.deferred-income-tax

072.665.7-333.3
6.6
35.9
159.1
7.5
-7.3
28.5
21.5
1.9
0
0
-5.5
1
0
0

cash-flows.row.stock-based-compensation

0322722.3
31.2
31.3
44
33.8
29.2
25.5
26.2
19.8
17.6
11.7
7.5
5.2
2.8
1.2

cash-flows.row.change-in-working-capital

011.32.817.7
-0.9
-100
7.6
-21.8
-5
-38.2
-30.1
-35.7
-27.1
-34.4
-21.3
58.2
20.7
45.2

cash-flows.row.account-receivables

00.987.7
4.1
-68.9
1.2
-17.3
-10.3
-28.7
-23.7
-1.7
-0.8
2.2
2.3
-0.5
18.4
-24.3

cash-flows.row.inventory

0000
0.6
0.7
-0.8
0.3
1.3
3.7
-3.1
-11.9
-6.7
1.3
-9.3
1.7
0
0

cash-flows.row.account-payables

012.4-8.1-2.6
-7.5
-32.7
8.1
-6.8
19.7
-1.6
1.4
-11.7
24.2
5.1
2.7
1.6
0
0

cash-flows.row.other-working-capital

0-22.912.7
1.8
0.9
-0.8
2
-15.6
-11.7
-4.8
-10.3
-43.8
-43
-17.1
55.4
2.3
69.5

cash-flows.row.other-non-cash-items

01068.21.725.2
22.3
16.4
-13.4
-16.8
28.1
8.4
4.1
1.7
1.2
2.2
1.6
-0.4
0.5
-1.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.3-0.1-0.3
-1.8
-7.2
-8.6
-4.2
-104.2
-4
-3.5
-9.6
-14
-9.7
-17.2
-4
-22.9
-2.7

cash-flows.row.acquisitions-net

0-102600
0
0.3
0
0
100
0
0
0
0
0
9.5
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
-3.2
-191.4
-311.1
-282
-254
-287.9
-96.7
-97.5
-441.8
-26.7
-82.6
-87.8

cash-flows.row.sales-maturities-of-investments

0000
0
0
99.2
346.9
237.4
276.7
201
196.1
140.8
222.3
236.5
48.5
90.5
62.9

cash-flows.row.other-investing-activites

0000
0
-4.2
1.6
0.1
-99.8
0.1
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-1026.3-0.1-0.3
-1.8
-11.1
88.9
151.5
-177.7
-9.2
-56.6
-101.4
30.1
115.1
-213
17.8
-15.1
-27.6

cash-flows.row.debt-repayment

0-300-120.70
0
-156.4
-1.8
-137.5
-28.8
-14
-2.2
-0.8
-0.3
-0.3
-2
-1.5
-1.7
-0.9

cash-flows.row.common-stock-issued

06.49.519.6
18.5
13.6
0
0
0
0
190.4
137.8
85.2
0
203.2
40.3
0
0

cash-flows.row.common-stock-repurchased

00-126.4-24.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-111.20
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0570.8111.2-4.5
18.5
141.6
31.9
157.3
24.6
317.1
22.7
176.6
4
3.4
1.7
2.9
50.2
51.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0277.2-237.6-4.5
18.5
-1.2
30.1
19.8
-4.2
303.1
210.9
313.6
89
3.1
203
41.7
48.6
50.7

cash-flows.row.effect-of-forex-changes-on-cash

0-0.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-565.336.1257.1
185.5
-1.6
48.1
71.7
-207.3
187
-1.2
-61.2
49.4
43
-78
55.4
5.3
16.4

cash-flows.row.cash-at-end-of-period

092.2657.9621.9
364.8
179.2
180.8
125.7
54
261.3
74.3
75.5
136.7
87.3
44.3
123.1
67.7
62.4

cash-flows.row.cash-at-beginning-of-period

0657.5621.9364.8
179.2
180.8
132.8
54
261.3
74.3
75.5
136.7
87.3
44.3
122.3
67.7
62.4
46.1

cash-flows.row.operating-cash-flow

0183.4273.8261.9
168.8
10.7
-70.9
-99.6
-25.4
-106.9
-155.6
-273.4
-69.6
-75.2
-67.9
-4
-28.2
-6.8

cash-flows.row.capital-expenditure

0-0.3-0.1-0.3
-1.8
-7.2
-8.6
-4.2
-104.2
-4
-3.5
-9.6
-14
-9.7
-17.2
-4
-22.9
-2.7

cash-flows.row.free-cash-flow

0183.2273.6261.6
167
3.5
-79.5
-103.8
-129.6
-111
-159.1
-282.9
-83.6
-84.9
-85.1
-8
-51.1
-9.4

利润表行

Ironwood Pharmaceuticals, Inc. 的收入与上期相比变化了 NaN%。据报告, IRWD 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

0442.7410.6413.8
389.5
428.4
346.6
298.3
274
149.6
76.4
22.9
150.2
65.9
43.9
36.1
22.2
10.5

income-statement-row.row.cost-of-revenue

01.61.41.5
3.1
23.9
32.8
19.4
1.9
0
25.6
7.2
1
0
0
0
0
0

income-statement-row.row.gross-profit

0441.2409.2412.2
386.4
404.5
313.9
278.9
272.1
149.5
50.9
15.7
149.3
65.9
43.9
36.1
22.2
10.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0.5
8.1
6.2
1
17.6
0.7
42.1
16
0
0
24
18.3
10.8

income-statement-row.row.operating-expenses

0232.1160.3181.5
228.1
287.5
415.9
387.6
313.8
234
220.2
267.7
222
132
104.6
108.9
78.1
68.1

income-statement-row.row.cost-and-expenses

0233.7160.3181.5
231.2
311.4
448.7
407
315.6
234
245.8
274.9
223
132
104.6
108.9
78.1
68.1

income-statement-row.row.interest-income

0199.50.7
1.5
2.9
3
2.1
1.2
0.4
0.3
0.2
0.2
0.5
0.6
0.2
2.1
4.1

income-statement-row.row.interest-expense

021.67.631.1
29.5
36.6
34.7
34.3
38
30.7
21.2
21
0.1
0.1
0.2
0.5
0.3
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1157.12.1-31.6
-34.1
-61.2
-145.6
26
-2.1
-27.6
0.7
-20.8
0.1
0.9
1.4
-0.6
-0.9
0.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0.5
8.1
6.2
1
17.6
0.7
42.1
16
0
0
24
18.3
10.8

income-statement-row.row.total-operating-expenses

0-1157.12.1-31.6
-34.1
-61.2
-145.6
26
-2.1
-27.6
0.7
-20.8
0.1
0.9
1.4
-0.6
-0.9
0.6

income-statement-row.row.interest-expense

021.67.631.1
29.5
36.6
34.7
34.3
38
30.7
21.2
21
0.1
0.1
0.2
0.5
0.3
0.3

income-statement-row.row.depreciation-and-amortization

01.69.50.7
16.9
0.3
8.1
6.2
1
11.6
12.3
11.7
11.3
10
6.2
5.3
2.8
1.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0209250.3232.3
142.9
120.1
-238.9
-77.4
-51.9
-102.1
-169.4
-252
-72.8
-66.1
-60.8
-72.8
-55.9
-57.6

income-statement-row.row.income-before-tax

0-948.1252.4200.7
108.9
58.9
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.8
-59.4
-73.6
-55
-53.2

income-statement-row.row.income-tax-expense

083.577.4-327.8
2.7
74.3
-5.8
34.3
38
19
8.6
-11.7
-11.3
0
-2.9
-0.3
-0.8
-0.1

income-statement-row.row.net-income

0-1002.2175.1528.4
106.2
-15.3
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.9
-53
-71.2
-53.9
-52.8
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

常见问题

什么是 Ironwood Pharmaceuticals, Inc. (IRWD) 总资产是多少？

Ironwood Pharmaceuticals, Inc. (IRWD) 总资产为 471073000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.996.

什么是公司自由现金流？

自由现金流为 1.174.

什么是企业净利润率？

净利润率为 -2.264.

企业总收入是多少？

总收入为 -2.120.

什么是 Ironwood Pharmaceuticals, Inc. (IRWD) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -1002239000.000.

公司总债务是多少？

债务总额为 715538000.000.

营业费用是多少？

运营支出为 232124000.000.

公司现金是多少？

企业现金为 0.000.